Wird geladen...
Cediranib Phase II Study in Children with Metastatic Alveolar Soft Part Sarcoma (ASPS).
BACKGROUND: ASPS, a rare vascular sarcoma with clinically indolent course, frequently presents with metastases. Vascular endothelial growth factor (VEGF) is a promising therapeutic target. In a phase II trial of the VEGF receptor inhibitor cediranib for adults with ASPS, the partial response (PR) ra...
Gespeichert in:
| Veröffentlicht in: | Pediatr Blood Cancer |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6803032/ https://ncbi.nlm.nih.gov/pubmed/31502400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.27987 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|